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SUMMARY 
Aims: Bacillithiol (BSH) is utilized as major thiol-redox buffer in the human pathogen Staphylococcus 
aureus. Under oxidative stress, BSH forms mixed disulfides with proteins, termed as S-bacillithiolation 
which can be reversed by bacilliredoxins (Brx). In eukaryotes, glutaredoxin-fused roGFP2 biosensors 
have been applied for dynamic live-imaging of the glutathione redox potential. Here, we have 
constructed a genetically encoded bacilliredoxin-fused redox biosensor (Brx-roGFP2) to monitor 
dynamic changes in the BSH redox potential in S. aureus. Results: The Brx-roGFP2 biosensor 
showed a specific and rapid response to low levels bacillithiol disulphide (BSSB) in vitro which required 
the active-site Cys of Brx. Dynamic live-imaging in two methicillin-resistant S. aureus (MRSA) USA300 
and COL strains revealed fast and dynamic responses of the Brx-roGFP2 biosensor under 
hypochlorite and H2O2 stress and constitutive oxidation of the probe in different BSH-deficient mutants. 
Furthermore, we found that the Brx-roGFP2 expression level and the dynamic range is higher in S. 
aureus COL compared to the USA300 strain. In phagocytosis assays with THP-1 macrophages, the 
biosensor was 87 % oxidized in S. aureus COL. However, no changes in the BSH redox potential 
were measured after treatment with different antibiotics classes indicating that antibiotics do not cause 
oxidative stress in S. aureus. Conclusion and Innovation: This Brx-roGFP2 biosensor catalyzes 
specific equilibration between the BSH and roGFP2 redox couples and can be applied for dynamic 
live imaging of redox changes in S. aureus and other BSH-producing Firmicutes.  
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INTRODUCTION 
Staphylococcus aureus is an opportunistic human pathogen causing local skin infections, but also life-
threatening diseases like septicemia, endocarditis and necrotizing pneumoniae (1,3,21). The success 
of the pathogen is mediated by virulence factors and by the development of multiple antibiotic resistant 
S. aureus strains, such as methicillin-resistant isolates (MRSA) (19). S. aureus has to cope with 
oxidative stress by reactive oxygen species (ROS), such as H2O2 and the strong oxidant hypochloric 
acid by the oxidative burst of macrophages and neutrophils under infection conditions (41). As defense 
mechanisms, S. aureus uses various redox-sensing virulence regulators and the thiol-redox-buffer 
bacillithiol (BSH) (5,13,20,28,30,32-34). BSH functions in detoxification of ROS, hypochlorite, diamide, 
methylglyoxal, electrophiles and antibiotics, such as rifampicin and fosfomycin or heavy metal ions 
and protects S. aureus against the oxidative burst by activated macrophages in phagocytosis assays 
(10,20,32,33). Under hypochlorite stress, BSH forms mixed disulfides with proteins 
(S-bacillithiolations) as a widespread thiol-protection and redox-switch mechanism analogous to 
S-glutathionylation in eukaryotes (6,7,17,20). In B. subtilis, two glutaredoxin-like enzymes YphP 
(BrxA) and YqiW (BrxB) with unusual CGC motifs were characterized as bacilliredoxins (Figures 1A 
and S1) that catalyze the reduction of S-bacillithiolated proteins, leading to formation of bacillithiolated 
Brx (Brx-SSB) as intermediate of this bacilliredoxin electron pathway (9). Reduction of Brx-SSB 
requires BSH resulting in BSSB formation that could be recycled by the putative BSSB reductase 
(YpdA) on expense of NADPH (Figure 1B) (9,10,12,20).  
The standard thiol-redox potential of BSH was calculated as E0'(BSSB/BSH) = -221mV which 
is higher than the glutathione redox potential [E0'(GSSG/GSH) = -240 mV] (31,36). To date, all 
previous studies have used fluorescent bimane-labelling of thiols for quantification of BSH and BSSB 
levels by high-pressure liquid chromatography (HPLC) under control and stress conditions as indicator 
of the changes in the BSH redox potential. According to this method, the BSH/BSSB ratios range from 
100:1 to 400:1 in B. subtilis, suggesting that BSH is mostly present in its reduced form (36). Under 
conditions of S-bacillithiolation provoked by NaOCl stress, the level of BSSB increases indicating a 
more oxidized BSH redox potential (7). However, the applied methods require disruption of cells and 
do not allow dynamic measurements of the changes in the BSH redox potential (25,35). Thus, recent 
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advances in the design of genetically encoded redox biosensors, such as redox sensitive green 
fluorescent proteins (roGFPs) have facilitated the real-time imaging of the cellular redox potential 
without cell disruption and at high sensitivity under in vivo conditions (11,24,35). These roGFP 
biosensors allow the ratiometric measurements based on two excitation maxima at 405 and 488 nm 
that change upon oxidation (24,25). RoGFP2 was fused to human glutaredoxin to construct the Grx-
roGFP2 biosensor for real-time measurements of dynamic changes in the GSH redox potential (EGSH) 
in different compartments and different eukaryotic organisms. Grx-roGFP2 detects nanomolar 
concentrations of GSSG against a backdrop of millimolar GSH within seconds (11,24). Recently, 
roGFP-based biosensors were applied in pathogenic organisms to study EGSH changes under infection 
conditions and antibiotic treatment, including the malaria parasite Plasmodium falciparum (15) and 
the Gram-negative bacterium Salmonella Typhimurium (38,39). In malaria parasites, several 
antimalarial drugs affected the cellular redox metabolism and showed differential responses of the 
Grx-roGFP2 biosensor under short- and long-term measurements in vivo (15). In Mycobacterium 
tuberculosis, an analogous Mrx1-roGFP2 biosensor was developed for dynamic measurements of the 
mycothiol redox potential (EMSH) in drug-resistant isolates and inside macrophages (2,24). The Mrx1-
roGFP2 biosensor was applied to screen for new ROS-generating anti-TB drugs that affected EMSH 
(37).  
In this study, we have constructed the first bacilliredoxin-fused roGFP biosensor that is highly 
specific to measure changes of the BSH redox potential in methicillin-resistant Staphylococcus aureus 
(MRSA) strains USA300 and COL under oxidative stress and following infection of THP-1 human 
macrophage-like cells.  
 
Results 
Construction of a Brx-roGFP2 biosensor that is highly specific for BSSB. The thioredoxin-fold 
proteins of the UPF0403 family YphP and YqiW were characterized as bacilliredoxins (BrxA and BrxB) 
in B. subtilis that function in reduction of S-bacillithiolated proteins and share an unusual CGC active 
site motif (Figure 1A) (9). Both Brx were S-bacillithiolated at their active site Cys in vivo and in vitro 
to form Brx-SSB during their catalytic cycle (9). Blast searches identified two bacilliredoxin homologs 
Overlay 
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in S. aureus USA300 (SAUSA300_1321 and SAUSA300_1463). SAUSA300_1321 showed 54 % 
sequence identity with YphP while SAUSA300_1463 shared stronger sequence identity (68 %) with 
YqiW of B. subtilis (Figure S1). We selected the YphP-homolog SAUSA300_1321 (renamed Brx) for 
construction of a Brx-roGFP2 fusion protein. S. aureus Brx and Brx Cys-Ala-mutant proteins 
(BrxA54GC56, BrxC54GA56, BrxA54GA56) were each fused via the 30aa glycine-serine linker (11) to the 
N-terminus of roGFP2 to construct the Brx-roGFP2 biosensor variants. Analogous to the reaction of 
Grx1-roGFP2 and Mrx1-roGFP2 with GSSG or MSSM (2,24), oxidation of the Brx-roGFP2 biosensor 
should occur specifically by BSSB that targets the active site Cys54 of Brx to form Brx-SSB. This leads 
to the transfer of the BSH moiety to the coupled roGFP2 forming S-bacillithiolated roGFP2 which re-
arranges to the roGFP2 disulfide resulting in ratiometric changes of the excitation maxima at 405 and 
488 nm (Figure 1C).  
The His-tagged Brx-roGFP2 protein was expressed in E. coli, purified and compared to 
roGFP2 for its ratiometric changes in the fully reduced and oxidized forms using the microplate reader. 
The thiol-reactive oxidant diamide was used for complete oxidation and the thiol-reducing compound 
DTT was applied for complete reduction of the biosensor. Similar to roGFP2, Brx-roGFP2 exhibits two 
excitation maxima at 405 and 488 nm and responds in a ratiometric manner to 5 mM diamide and 
10 mM DTT (2,24) (Figure 1DE). The degree of oxidation (OxD) was calculated according to the 
fluorescence excitation intensities at 405 nm and 488 nm of fully oxidized and reduced Brx-roGFP2 
probes as described previously (11). For all following measurements the OxD values of fully reduced 
and oxidized probes were calibrated as 0 and 1 and the OxD of the actual measurements were related 
to these controls. Furthermore, it was analysed if the Brx-roGFP2 response is sensitive by pH changes 
that could occur during infections. The Brx-roGFP2 probe was diluted into phosphate buffer solutions 
at different pH values ranging from 5.8 to 8.0 and treated with diamide and DTT (Figure S2). The 
405/488 nm excitations ratios were not affected by different pH values indicating that the probe is 
insensitive to pH changes.  
 Purified Brx-roGFP2 showed a very fast and specific response to physiological BSSB levels 
(10-100 µM), but not to other thiol disulfides (GSSG, MSSM, cystine and CoAS disulfide) (Figure 
2AB). In contrast, roGFP2 did not respond to 10-100 µM BSSB confirming that Brx-roGFP2 is specific 
Loi et al., 2016   Brx-roGFP2 redox biosensor in S. aureus 
 
6 
 
to detect EBSH changes (Figure 2C). Furthermore, Grx-roGFP2 was oxidized specifically by 100 µM 
GSSG, but was unresponsive to BSSB indicating that Grx is not specific for the BSH/BSSB redox 
couples (11) (Figure 2D).  
The specificity of Brx for BSSB should be determined by the C54GC56 active site motif. Hence, 
the response of Brx-roGFP2 was compared with that of Brx Cys mutant roGFP2 fusions where the 
active site Cys54 and the resolving Cys56 of Brx are each replaced by an alanine (BrxAGC, BrxCGA, 
BrxAGA). While Brx-roGFP2 and the resolving Brx Cys56 mutant (BrxCGA-roGFP2) showed very fast 
oxidation by 10-100 µM BSSB, the BrxAGC-roGFP2 and BrxAGA-roGFP2 active site mutant proteins 
failed to respond to 10 µM BSSB and showed weaker responses to 100 µM BSSB (Figure 2EF). In 
previous studies, the BSH content was determined as 0.5-1.6 µmol/g raw dry weight (rdw) in BSH-
producing S. aureus strains (36). This equates to 0.5-1.6 mM intracellular BSH assuming a 50% water 
content of the cellular biomass as determined for related bacteria (4). The BSH/BSSB ratio was 
estimated as 1:20-1:40 (28,32) indicating that the physiological BSSB content should be below 
100 µM in S. aureus. Thus, the Brx-roGFP2 biosensor is highly specific to detect physiological levels 
of 10-100 µM BSSB in vitro.  
 
Response of Brx-roGFP2 in S. aureus MRSA strains COL and USA300 along the growth curve 
and effect of BSH deficiency on the biosensor response. To monitor the changes in EBSH inside 
S. aureus, Brx-roGFP2 was expressed ectopically from plasmid pRB473 under control of a xylose-
inducible promoter in two MRSA isolates COL and USA300. The S. aureus wild type strains were 
grown in LB medium overnight with xylose and the strong roGFP2 fluorescence could be monitored 
using the microplate reader and fluorescence microscopy. First, we confirmed the ratiometric 
response of the Brx-roGFP2 biosensor inside S. aureus cells in the fully oxidized and reduced state 
after treatment with 5 mM diamide and 10 mM DTT, respectively and monitored the changes at the 
405 and 488 nm excitation maxima (Figure 3AB). Western blot analyses confirmed that Brx-roGFP2 
is expressed as full-length protein and not degraded during the growth in S. aureus (Figure S3). Next, 
the changes of the BSH redox potential were monitored during different stages of growth in LB medium 
in S. aureus (Figure 3C-E). In fact, the expression and fluorescence intensity of Brx-roGFP2 varied 
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between the S. aureus COL and USA300 wild type strains along the growth. While a significant Brx-
roGFP2 fluorescence signal was detected in S. aureus COL already during the exponential growth, 
the expression and fluorescence of Brx-roGFP2 were much weaker in S. aureus USA300 during the 
log phase (Figure 3CD, Figure S4AB). In both strains, the oxidation degree of the Brx-roGFP2 
increased during the stationary phase reflecting growth-dependent redox changes (Figure 3E). 
Furthermore, we observed that the dynamic range of the 405/488 nm ratios of fully reduced and 
oxidized Brx-roGFP2 was higher in COL (3.77 ± 0.65) compared to USA300 (2.37 ± 0.98) (Figure 3F). 
However, we confirmed that the level of Brx-roGFP2 did not affect the OxD since serial dilutions of S. 
aureus cells that were harvested at an OD of 4.0 showed the same OxD level (Figure S4CD). Based 
on the oxidation degree of the biosensor, the intracellular BSH redox potential was calculated using 
the Nernst’ equation, ranging from -300 to -270 mV in COL and from -300 to -235 mV in USA300 
during exponential growth until transition into the stationary phase (Table S5).  
We further compared biosensor oxidations between COL and USA300 wild types and isogenic 
BSH deficient mutants. The biosensor was fully oxidized in the COL and USA300 bshA mutants 
indicating an impaired redox balance and increased oxidative stress in the bshA mutant (Figure 3GH). 
This constitutive biosensor oxidation was also observed in strain RN4220 which is a natural bshC 
mutant of the S. aureus NCTC8325 lineage (27,32,33) (Figure S5). Western blot analyses confirmed 
that the biosensor is similarly expressed in the COL wild type and bshA mutant (Figure S6). 
 
Response of Brx-roGFP2 in S. aureus COL to oxidative stress. The changes in EBSH were further 
investigated in S. aureus COL wild type in response to oxidative stress, provoked by H2O2 and NaOCl. 
Previous studies have shown that NaOCl stress leads to S-bacillithiolation of proteins and a decreased 
BSH/BSSB redox ratio (7). Since S. aureus is extremely resistant to H2O2 (14,40), the physiological 
sub-lethal concentrations of oxidants were determined (Figure 4AB). In addition, the role of BSH for 
the resistance to NaOCl and H2O2 was analyzed in survival assays. The bshA mutant was more 
sensitive than the wild type to 150 µM NaOCl and 300 mM H2O2 indicating that BSH contributes to 
oxidative stress resistance. The change in EBSH after exposure to 1-100 mM H2O2 and 10-100 µM 
NaOCl and the time for detoxification of oxidants and recovery of the reduced state were investigated. 
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The biosensor was rapidly and reversibly oxidized by 10-50 mM H2O2 and cells approached a more 
reduced state within 70 minutes (Figure 4C). Remarkably, 100 mM H2O2 did not result in complete 
oxidation of the biosensor (e.g. OxD = 1), although S. aureus cells were unable to restore their 
reduced state. Treatment of cells with low doses of 10-20 µM NaOCl resulted in reversible biosensor 
oxidation and required 200 min for regeneration of the reduced state. The biosensor was fully oxidized 
by 100 µM NaOCl, but cells were unable to recover (Figure 4D). Using non-reducing BSH-specific 
Western blot analysis we further confirmed that 100 µM NaOCl stress leads to the same increase of 
S-bacillithiolated proteins in S. aureus COL and COL Brx-roGFP2 strains indicating that Brx-roGFP2 
expression did not affect the S-bacillithiolation pattern (Figure S7).  
To analyse the impact of Brx in the biosensor response to the oxidants in vivo, attempts were 
made to express also unfused roGFP2 in S. aureus COL. However, in contrast to the Brx-roGFP2 
fusion, expression of unfused roGFP2 failed in S. aureus COL containing the pRB473-roGFP2 
plasmid. Thus, we compared the biosensor responses of the various Brx Cys mutant fusions (BrxAGC, 
BrxCGA, BrxAGA) to the different oxidants in vivo. The response of Brx-roGFP2 and BrxCGA-roGFP2 
to 50 mM H2O2 was fast and reversible with recovery of the reduced state after 120 min. In contrast, 
oxidation of the Brx active site Cys mutant fusions (BrxAGC and BrxAGA) by H2O2 was slower and 
not fully reversible (Figure 4E). We further analysed the responses of the BrxAGC, BrxCGA and 
BrxAGA Cys mutant fusions to 20 µM NaOCl. While all Brx Cys mutants responded similar to NaOCl, 
the BrxAGA double Cys mutant was unable to recover after 120 min (Figure 4F). This indicates that 
a direct response of Brx-roGFP2 to high doses of 50 mM H2O2 and to the strong oxidant NaOCl could 
in part account for the oxidant responses in the absence of the CGC motif of Brx. To monitor the direct 
biosensor response to the oxidants, purified roGFP2 and Brx-roGFP2 proteins were both treated with 
different concentrations of H2O2 and NaOCl (Figure S8). The results showed, that roGFP2 and Brx-
roGFP2 both respond strongly to 1-10 mM H2O2 and 50-100 µM NaOCl leading to complete biosensor 
oxidation. This confirms that the Brx-roGFP2 biosensor could also directly respond to high H2O2 doses 
and the strong oxidant NaOCl in vivo in the absence of the Brx CGC motif. Another possibility could 
be that the third conserved Cys of Brx at the C-terminus (Cys144) is S-bacillithiolated by BSSB in vivo 
in the absence of the CGC motif leading to subsequent biosensor oxidation. 
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Confocal laser scanning microscopy of Brx-roGFP2 fluorescence in S. aureus COL wild type 
and ∆bshA mutant cells. The redox-dependent changes of Brx-roGFP2 fluorescence in S. aureus 
COL wild type and bshA mutant cells were analyzed using confocal laser scanning microscopy before 
and after NaOCl stress. The biosensor fluorescence intensities were measured after excitation at 
405 nm and 488 nm and false-coloured in red and green, respectively (Figure 5). The oxidation state 
of the biosensor is visualized by overlay of both red and green images. Confocal imaging showed that 
Brx-roGFP2 is reduced in non-treated wild type cells and resembles that of DTT-treated reduced cells 
with bright fluorescence at the 488 nm excitation wavelength (Figures 5). NaOCl stress leads to a 
decreased fluorescence intensity of the 488 nm excitation maximum and strongly increased 
fluorescence at the 405 nm excitation maximum as shown in the histograms. Thus, NaOCl-treated 
wild type cells are visualized as red cells in the overlay images similar to the fully oxidized wild type 
control. In the S. aureus COL bshA mutant the Brx-roGFP2 biosensor was fully oxidized under control 
conditions as shown by the strong fluorescence in the 405 nm (red) channel which resembles the 
NaOCl-treated sample. The redox state of wild type and bshA mutant cells was calculated from five 
representative single cells and also using measurements in the microplate reader for comparison 
(Figures 5 CD).  
 
Response of Brx-roGFP2 in S. aureus following internalization by THP-1 macrophages. Next, 
we measured the changes in EBSH of S. aureus under infection-like conditions during phagocytosis 
assays with activated THP-1 macrophages. Infection assays were performed with S. aureus COL cells 
at a multiplicity of infection (MOI) of 25 and fluorescence excitation intensities were monitored at 405 
and 488 nm. After 1 hour of infection with S. aureus COL about 70-80 % of THP-1 cells showed a 
green fluorescence. As fully oxidized and reduced controls, infected macrophages were treated with 
150 µM NaOCl and 20 mM DTT, respectively and the mean fluorescence intensity (MFI) at 405 and 
488 nm was analysed using flow cytometry (Table S7). The 405/488 nm ratio of the MFI of fully 
reduced and oxidized THP-1 controls was calibrated to 0% and 100% oxidation and related to the 
405/488 nm ratio of the MFI of infected macrophages. In comparison to these fully reduced and 
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oxidized THP-1 controls, the biosensor was 87 % oxidized in S. aureus COL during infection following 
uptake by macrophage-like cells (Table S7).  
 
Effects of antibiotics on the Brx-roGFP2 biosensor response in S. aureus COL. We were 
interested in the changes of the BSH redox potential in response to sub-lethal antibiotics commonly 
used to treat MRSA infections. The aim was to clarify a long debate about the involvement of oxidative 
stress in the killing mode of antibiotics (16,18). We have chosen antibiotics with different cellular target 
sites, including RNA polymerase inhibitors (rifampicin), cell-wall biosynthesis inhibitors (fosfomycin, 
ampicillin, oxacillin and vancomycin), aminoglycosides as protein biosynthesis inhibitors that target 
the ribosome (gentamycin, lincomycin, erythromycin and linezolid), as well as fluoroquinolones 
(ciprofloxacin) that inhibits the DNA gyrase and topoisomerase IV to block DNA replication. S. aureus 
COL with Brx-roGFP2 was treated with sub-lethal concentrations of antibiotics and analyzed for its 
biosensor response. The sub-lethal antibiotics doses that caused a reduced growth rate were 
determined as 0.1 μM erythromycin, 0.1 μM rifampicin, 5 μM vancomycin, 30 μM ciprofloxacin, 
0.5 μg/ml gentamicin, 10 μM ampicillin, 50 mM fosfomycin, 5 μM lincomycin, 2 μg/ml linezolid and 
2 mM oxacillin. The measurement of the Brx-roGFP2 response revealed no increased biosensor 
oxidation by any of these antibiotics compared to the untreated control (Figure 6, Table S6). These 
results document that sub-lethal antibiotics do not cause changes in the BSH redox potential in S. 
aureus.  
 
DISCUSSION 
Redox-sensitive GFPs have been recently fused to glutaredoxin and mycoredoxin for dynamic 
measurements of the intracellular redox potential in eukaryotes and Mycobacteria in real-time and at 
high sensitivity and spatiotemporal resolution (35). Here, we coupled the bacilliredoxin (Brx) to roGFP2 
to measure the intracellular bacillithiol (BSH) redox potential in S. aureus cells under infection 
conditions, ROS and antibiotics treatments. This Brx-roGFP2 biosensor is highly sensitive and specific 
for physiological levels of BSSB while unfused roGFP2 and the BrxAGC active site mutant roGFP2 
fusion are much lower responsive to BSSB in vitro. The role of the active site Cys of Brx for reduction 
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of S-bacillithiolated OhrR and MetE has been shown previously for B. subtilis BrxA and BrxB (9). The 
specific reaction of the active site Cys54 with BSSB was verified here for the S. aureus Brx homolog 
SAUSA300_1321 in the Brx-roGFP2 fusion. Thus, coupling of roGFP2 with the Brx facilitates rapid 
equilibration of the biosensor with the BSH/BSSB redox pair to selectively measure changes in the 
BSH redox potential. However, weaker responses of the BrxAGC and BrxAGA active site and double 
mutants were observed by 100 µM BSSB which could depend on the third C-terminal Cys144 residue 
that is also conserved across the UPF0403-family of Brx-homologs (Figure S1). 
The Brx-roGFP2 biosensor was applied to monitor the changes in the BSH redox potential 
inside the archaic HA-MRSA isolate COL and the CA-MRSA strain USA300. In both MRSA strains, 
BSH is required for survival under oxidative stress and infection-related conditions during 
phagocytosis with macrophages (32,33). Here, we confirmed that BSH-deficient mutants of S. aureus 
COL and USA300 are more sensitive to H2O2 and NaOCl compared to the wild types. We further 
monitored the perturbations in the BSH redox potential during growth, oxidative challenge and 
infection assays with THP-1 macrophages. Increases in EBSH were observed in S. aureus COL and 
USA300 strains during the stationary phase in LB medium compared to the log phase. However, we 
confirmed that the expression level of Brx-roGFP2 did not affected the OxD (Figure S4 CD). The 
dynamic range of Brx-roGFP2 was lower in USA300 compared to COL which could depend on the 
1.6-fold higher BSH levels in USA300 (32). Differences in the basal level oxidation and dynamic range 
were also observed between drug-sensitive (3D7) and resistant (Dd2) Plasmodium falciparum 
parasites (15). In P. falciparum 3D7, the lower basal oxidation degree of the biosensor could be 
explained by the higher GSH levels. Thus, the higher BSH levels in USA300 could result in higher 
reducing capacity and lower biosensor response to diamide.  
We further showed that the Brx-roGFP2 biosensor in S. aureus COL responds rapidly to ROS, 
such as H2O2 and NaOCl. However, S. aureus is resistant to high levels of 300 mM H2O2 (40). Thus, 
treatment of S. aureus with 1-10 mM H2O2 resulted only in a slightly increased biosensor oxidation 
with rapid regeneration of the reduced state. Exposure to 50-100 µM NaOCl stress caused the 
complete and constitutive oxidation of the biosensor and correlates with the observed S-
bacillithiolation of proteins and increased levels of BSSB under NaOCl stress in S. aureus (7). The 
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comparison of the biosensor response of Brx-roGFP2 with that of the Brx Cys mutant fusion revealed 
similar response but changes in the recovery after H2O2 and NaOCl stress which was impaired in the 
Brx active site mutants. Thus, the biosensor could also directly respond to the high H2O2 levels and 
the strong oxidant NaOCl in vivo. The changes in BSH redox potential were also measured inside S. 
aureus COL during phagocytosis assays in THP-1 macrophage cell lines. The flow cytometric data 
showed that the Brx-roGFP2 biosensor was 87 % oxidized in S. aureus COL under infection 
conditions. 
The comparison of the biosensor response in S. aureus COL and USA300 wild types and the 
isogenic bshA mutants as well as in the natural bshC-deficient strain RN4220 revealed a constitutive 
oxidation of the probe in the absence of BSH. This high biosensor oxidation in BSH-deficient strains 
is visualized also by confocal imaging at the cellular level. These results are in agreement with the 
constitutive oxidation of the Grx-roGFP2 biosensor upon GSH depletion in Arabidopsis thaliana seeds 
(23). Thus, our data clearly document the impaired redox balance in the absence of BSH and its major 
role to keep the reduced state of the cytoplasm in S. aureus cells. In addition to BSH depletion, much 
lower NADPH levels were previously measured in the ΔbshA mutant which could contribute to the 
impaired thiol-redox balance (32). In S. aureus, coenzyme A and Cys were suggested to function as 
alternative thiol-redox buffers and S. aureus encodes also a CoAS disulfide reductase to keep CoASH 
in the reduced state (22). However, based on the microscopic and macroscopic pKa values of BSH, 
the level of the reactive thiolate anion is much higher in BSH compared to CoASH and Cys at 
physiological pH values (36). Thus, only BSH is the available nucleophilic thiol that reacts with protein 
disulfides formed under oxidative stress in S. aureus (29). Consistent with this notion, neither cystine 
nor CoAS disulfide were recognized by Brx at physiological concentrations to oxidize our biosensor in 
vitro. Previous studies identified the OhrR-repressor as redox-controlled under organic peroxide and 
NaOCl stress by S-cysteinylation and S-bacillithiolation (6,17). BrxA and BrxB were specific for 
reduction and reactivation of S-bacillithiolated OhrR, but could not regenerate S-cysteinylated OhrR 
(9). These results further support our findings about the specificity of Brx of S. aureus for BSSB.  
 Finally, we studied the changes in the BSH redox potential in S. aureus after treatment with 
sub-lethal doses of different antibiotics to clarify the role of oxidative stress as killing mode for 
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antibiotics, a controversial debate among microbiologists (16,18). However, we could not detect 
changes in the BSH redox potential after treatment with rifampicin, fosfomycin, ampicillin, oxacillin, 
vancomycin, aminoglycosides and fluoroquinolones. Similar to our results, no roGFP2 response was 
detected by any of these antibiotics in Salmonella (39). However, S. aureus is resistant to 100 mM 
H2O2 without killing effect and thus, S. aureus might be resistant to ROS produced under antibiotics 
treatment.  
In conclusion, we have constructed a novel Brx-roGFP2 biosensor that is highly specific to 
sense the reduced pool of BSH inside S. aureus cells and responds to oxidative stress under infection-
like conditions inside macrophages. Using this novel tool, we could demonstrate that commonly used 
antibiotics do not cause oxidative stress when applied to S. aureus and that BSH-deficient mutants 
have an impaired redox balance and reduced virulence. S. aureus is an important human pathogen 
with new MRSA strains and other multiple antibiotics resistant isolates emerging quickly. This novel 
probe can be applied in drug-research to screen for new redox-active antibiotics that affect the BSH 
redox potential in S. aureus.  In addition, the difference in the ROS detoxification capacity and 
resistance to host defenses can be monitored across emerging MRSA-isolates to understand the 
connection between virulence factor expression, antibiotics resistance and the BSH redox potential in 
S. aureus. 
 
INNOVATION 
In eukaryotes, glutaredoxin-fused roGFP2 biosensors have been successful applied for dynamic live-
imaging of the glutathione redox potential. Here, we have constructed the first genetically encoded 
bacilliredoxin-fused redox biosensor (Brx-roGFP2) that is specific to measure dynamic changes in the 
BSH redox potential in the human pathogen S. aureus under oxidative stress and infection conditions 
in vivo. Using this biosensor we could confirm that different antibiotics do not cause oxidative stress 
in S. aureus. This Brx-roGFP2 biosensor can be applied to measure redox potential changes across 
clinical S. aureus isolates and to screen for new redox-active antibiotics to treat MRSA infections.  
 
Experimental procedures 
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Bacterial strains, growth conditions, stress and antibiotics treatments. Bacterial strains, 
plasmids and primers are listed in Tables S1, S2 and S3. For cloning and genetic manipulation, 
Escherichia coli was cultivated in Luria Bertani (LB) medium. S. aureus strains with the pRB473-XylR-
Brx-roGFP2 plasmids were cultivated in LB medium with 1% xylose to ensure constitutive expression 
of the biosensor. For stress experiments, S. aureus cells were grown in LB until an optical density at 
540 nm (OD540) of 1.0 and transferred to Belitsky minimal medium (BMM) with 1% xylose. The fully 
reduced control cells were treated with 10 mM DTT and the fully oxidized control was treated with 5 
mM diamide for 20 min each, harvested with 10 mM N-ethylmaleimide (NEM) to block the biosensor 
redox state and transferred to the microplate wells. The samples for stress exposure were transferred 
to the microplates and different oxidants were injected into the wells of microplates. The Brx-roGFP2 
biosensor fluorescence emission was measured at 510 nm after excitation at 405 and 488 nm using 
the CLARIOstar microplate reader (BMG Labtech) as described below for the in vitro measurements. 
Three biological were performed for each stress experiment.   
For the survival assays, S. aureus COL wild type and the bshA mutant were treated with NaOCl 
and H2O2 at an OD500 of 1.0 in BMM and serial dilutions were plated on LB agar plates and counted 
for colony forming units (cfu). The survival assays were performed in three biological replicates for 
each strain.   
For the determination of the growth-inhibitory and sub-lethal antibiotics concentrations, S. 
aureus was cultivated in RPMI medium and the antibiotics erythromycin, rifampicin, vancomycin, 
ciprofloxacin, gentamicin, ampicillin, fosfomycin, lincomycin, linezolid or oxacillin were added at an 
OD500 of 0.5 to monitor the reduction in growth as described previously (8). The measurements of 
the biosensor responses after antibiotics treatment were performed in S. aureus Brx-roGFP2 cells 
grown in RPMI-medium and treated with sub-lethal antibiotics doses that reduced the growth rate. 
Cells were harvested after different times of antibiotics treatment, washed with PBS and blocked with 
NEM before the microplate reader measurements. Four biological replicates were performed for each 
antibiotics stress experiment. Sodium hypochlorite, diamide, dithiothreitol (DTT), hydrogen peroxide 
(H2O2, 35% w/v) and antibiotics (erythromycin, rifampicin, vancomycin, ciprofloxacin, gentamicin, 
ampicillin, fosfomycin, lincomycin, linezolid and oxacillin) were purchased from Sigma Aldrich.  
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Construction, expression and purification of Brx-roGFP2 in E. coli. The Grx-roGFP2 containing 
plasmid pQE60-Grx1-roGFP2 was obtained from Tobias Dick (11) and used as template for 
construction of the Brx-roGFP2 fusion. The brx gene (SAUSA300_1321) was amplified 
from chromosomal DNA of S. aureus USA300 by PCR using primers SAUSA300-1321yphP-FOR-
BamHI-NcoI and SAUSA300-1321yphP-REV-SpeI (Table S3), digested with BamHI and SpeI and 
inserted into plasmid pQE60-Grx1-roGFP2 that was digested using the same restriction enzymes to 
generate plasmid pQE60-Brx-roGFP2. The brx-roGFP2 sequence was amplified from plasmid 
pQE60-Brx-roGFP2 by PCR using primers 1321-roGFP2-FOR-NheI and roGFP2-REV-BamHI, 
digested with NheI and BamHI and sub-cloned into pET11b (Novagen) after digestion by the same 
enzymes to generate plasmid pET11b-Brx-roGFP2.  
For construction of the roGFP2 fusions with the Brx-Cys-to-Ala variants, the Cys residues of 
the C54GC56 active site were replaced by alanine using PCR mutagenesis. For the brxC54A mutant, 
two first-round PCR reactions were performed using primers SAUSA300-1321yphP-FOR-BamHI-NcoI 
and SAUSA300-1321-yphP-C56A-REV and primers SAUSA300-1321-yphP-C54A-FOR and 
SAUSA300-1321yphP-REV-SpeI. For the brxC56A mutant, two first-round PCRs were performed 
using primers SAUSA300-1321yphP-FOR-BamHI-NcoI and SAUSA300-1321-yphP-C56A-REV and 
primers SAUSA300-1321-yphP-C56A-FOR and SAUSA300-1321yphP-REV-SpeI. The two PCR 
products of each first round PCR reaction were hybridized and subsequently amplified by a second 
round of PCR using primers SAUSA300-1321yphP-FOR-BamHI-NcoI and SAUSA300-1321yphP-
REV-SpeI. The PCR products from the second-round PCRs were then digested with BamHI and SpeI 
and inserted into plasmid pQE60-Grx1-roGFP2 digested with the same enzymes. Subcloning of the 
Brx-Cys-to-Ala mutant roGFP2 fusions into pET11b was performed as described above.  
To construct the brxC54A-C56A double mutant, first-round PCR was performed using primers 1321-
roGFP2-FOR-NheI and 1321-brx-C54A56A-REV and primers 1321-brx-C54A56A-FOR and 
SAUSA300-1321yphP-REV-SpeI. Then, the PCR products from first round PCR reactions were fused 
by PCR using primers 1321-roGFP2-FOR-NheI and SAUSA300-1321yphP-REV-SpeI. The PCR 
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product from the second-round PCR was then digested with NheI and SpeI and inserted into plasmid 
pET11b-Brx-roGFP2 digested with the same enzymes. 
To construct plasmid pET11b-roGFP2, primers roGFP2-FOR-NheI and roGFP2-REV-BamHI 
were used to amplify roGFP2 from plasmid pQE60-Grx1-roGFP2. The PCR product was digested with 
NheI and BamHI and inserted into plasmid pET11b digested with the same enzymes. The correct 
sequences of all plasmid inserts were confirmed by PCR amplification and sequencing.  
For Brx-roGFP2 expression, Escherichia coli BL21(DE3) plysS containing the pET11-Brx-roGFP2 
plasmids was grown in 1 liter LB medium and 1 mM IPTG (isopropyl-β-D-thiogalactopyranoside) was 
added at the exponential phase (OD600 of 0.8) for 16 h at 25°C. Recombinant His-Brx-roGFP2 and 
the Brx-Cys-to-Ala mutant roGFP2 fusion proteins were purified using PrepEase His-tagged high-yield 
purification resin (USB) under native conditions according to the instructions of the manufacturer 
(USB). The purified proteins were extensively dialyzed against 10 mM Tris-HCl (pH 8.0), 100 mM 
NaCl, and 50% glycerol and stored at -80°C. 
 
Microplate reader measurements of Brx-roGFP2 and calculation of OxD and EBSH. To study the 
Brx-roGFP2 response in vitro, the purified proteins were reduced with 10 mM DTT for 20 min, desalted 
with Micro-Bio spin columns (Biorad) and diluted to 1 µM in 100 mM potassium phosphate buffer, pH 
7.0. Fluorescence excitation spectra of Brx-roGFP2 were analyzed before and after exposure to the 
oxidants using the CLARIOstar microplate reader (BMG Labtech) with the Control software version 
5.20 R5. Fluorescence excitation spectra were scanned from 360 to 500 nm with a bandwidth of 
10 nm, emission was measured at 510nm. Gain setting was adjusted for each excitation maximum. 
The data were analyzed using the MARS software version 3.10 and exported to Excel. Each in vitro 
measurement was performed in triplicate as indicated in the figure legend. The oxidation degree (OxD) 
of the biosensor was calculated using the equation (1) as described previously (24,25). 
OxD =
I405 x I488red−I405red x I488
I405 x I488red−I405 x I488ox+I405ox x I488−I405red x I488
 (1) 
The values I405 and I488 are the observed fluorescence excitation intensities at 405 nm and 488 nm, 
respectively. The values I405red, I488red I405ox and I488ox are the fluorescence excitation 
intensities at 405 nm and 488 nm of fully reduced and oxidized probes, respectively.  
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The biosensor redox potential EroGFP2 was calculated according to the Nernst equation (2) as described 
previously (25). 
EroGFP2 = EroGFP2
O′ − (
RT
2F
) ∗ ln (
(1−OxDroGFP2
OxDroGFP2
) (2) 
Because the biosensor equilibrates with the BSH/BSSB redox couple, EBSH = EroGFP2.  
 
Construction of Brx-roGFP2 fusions in S. aureus. The brx-roGFP2 sequence was amplified with 
primers SAUSA300-1321-FOR-BamHI-2 and roGFP2-REV-KpnI-3 and the forward primer also 
includes the shine-dalgarno sequence of the brx gene. The PCR product was digested with BamHI 
and KpnI and inserted into the pRB473-XylR shuttle vector that was digested using the same enzymes 
to generate pRB473-XylR-Brx-roGFP2. The plasmids were cloned in E. coli DH5 and electroporated 
into competent cells of S. aureus RN4220. The plasmids were transfered into the S. aureus target 
strains COL and USA300 by phage transduction using bacteriophage 80 as described previously (26). 
S. aureus transductants were selected on LB agar with chloramphenicol. The plasmids were isolated 
and confirmed by PCR and sequencing of the brx-roGFP2 fusion.  
 
Western blot analyses for Brx-roGFP2 expression and BSH-mixed disulfides in S. aureus. S. 
aureus strains with Brx-roGFP2 were grown in LB with 1% xylose and harvested at different times 
during the growth. Cells were washed in Tris-buffer (pH 8.0) with 10 mM NEM, disrupted using the 
ribolyzer and the protein extract was cleared from cell debris by repeated centrifugation. Protein 
amounts of 25µg were analyzed by Western blot analysis using mouse-anti-GFP monoclonal 
antibodies (Tebu Biosciences Cat.-No. 12616810949) as described previously (11). Quantification 
was performed using the ImageJ software (ver. 1.48, http://imagej.nih.gov) based on a standard curve 
with purified Brx-roGFP2. The BSH-mixed disulfides were analysed after exposure of S. aureus cells 
to 100 µM NaOCl using non-reducing SDS-PAGE and BSH-specific Western blot analysis with 
polyclonal rabbit BSH-antibodies as described previously (7).  
 
Confocal laser scanning microscopy of S. aureus Brx-roGFP2 strains. S. aureus strains with Brx-
roGFP2 were exposed to 150 µM of NaOCl, harvested before and after the stress, blocked with NEM 
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and analyzed by confocal laser scanning microscopy using a ZEISS LSM510meta. The microscope 
was equipped with a 100× 1.3 M27 EC plan-neofluar oil objective. Fluorescence excitation was 
performed at 405 and 488 nm and emission was measured using the 505-550nm band pass filter. 
Cells treated with 10 mM DTT and 5 mM diamide were used as fully reduced and oxidized controls, 
respectively. The argon/2 and 405 nm laser power were set to 20 and 8%, respectively. The smart 
gain was 948 V. All setting parameters for the CLSM are listed in Table S4. The microscope was 
calibrated with fully oxidized and reduced S. aureus Brx-roGFP2 controls. Quantification of the OxD 
values was performed from 5 cells each from each sample and the experiments were performed in 
two biological replicates.   
 
Flow cytometry of S. aureus Brx-roGFP2 strains during infection of THP-1 macrophage cell 
lines. For the infection assays we used the human monocytic leukemia cell line THP-1, which was 
purchased from the DSMZ strain collection in Heidelberg (DSMZ-no. ACC-16). The cell line was 
authenticated by multiplex PCR of minisatellite markers which revealed a unique DNA profile and the 
expression of fusion gene MLL-MLLT3 (MLL-AF9) was confirmed by RT-PCR. Cell cultures were 
checked for absence of mycoplasma contaminations by PCR on a regular basis. This cell line is not 
included in the database of commonly misidentified cell lines as maintained by ICLAC. THP-1 cells 
were cultivated in RPMI-1640 medium with 10% heat inactivated foetal bovine serum (FBS) and 
seeded in 60 mm cell culture dishes at a density of 4.5 x 106 cells. Differentiation was induced by 
100 nM phorbol 12-myristate 13-acetate (PMA) for 24 hours, followed by washing of cells with Hanks 
balanced salts solution (HBSS) and the addition of fresh medium without PMA. After 24 hours 
incubation, infection assays of THP-1 macrophages with S. aureus were performed as follows. First, 
S. aureus COL cells expressing Brx-roGFP2 were grown in LB with 1% xylose until OD540 of 0.5. 
Bacterial cells were harvested, washed twice and incubated in RPMI-1640 medium. Infection of THP-
1 cells with S. aureus Brx-roGFP2 was performed at a multiplicity of infection (MOI) of 25 for 1 hour. 
The infected THP-1 cells were washed twice in PBS-buffer, detached with 0.05% trypsin and 0.02% 
EDTA, centrifuged and re-suspended in PBS-buffer with 1% FBS. Measurement by flow cytometry 
was performed on an Attune Acoustic Focusing Cytometer (LifeTechnologies) with excitation at 405 
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and 488 nm and emission at 515-545 nm. Ten thousand events were gated and the mean 
fluorescence intensity (MFI) was determined with Attune software V2.1.0 or FlowJo V10.07 (Tree 
Star). For reduced and oxidized controls, infected THP-1 cells were treated with 20 mM DTT and 
150 µM NaOCl, respectively. Infection experiments were performed in 3 biological replicates. 
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LIST OF ABBREVIATIONS 
BMM   belitsky minimal medium 
Brx   bacilliredoxin 
BSH   bacillithiol 
BSSB  bacillithiol disulfide 
CA-MRSA  community-aquired MRSA 
CFU   colony-forming unit 
CLSM  confocal laser scanning microscopy 
CoASH coenzyme A 
DTT   dithiothreitol 
EDTA   ethylenediaminetetraacetic acid 
FBS   Foetal bovine serum 
Grx  glutaredoxin 
GSH   glutathione 
GSSG  oxidized glutathione disulfide 
H2O2  hydrogen peroxide 
HA-MRSA  hospital-acquired MRSA 
HBSS   Hanks balanced salts solution 
HPLC  high-pressure liquid chromatography 
IPTG  isopropyl- β -D-thiogalactopyranoside 
LB  Luria Bertani 
MFI   mean fluorescence intensity 
MOI   multiplicity of infection 
MRSA  methicillin-resistant Staphylococcus aureus 
Mrx1  mycoredoxin1 
MSH  mycothiol 
MSSM  mycothione or mycothiol disulfide  
NADPH nicotinamide adenine dinucleotide phosphate 
NaOCl  sodium hypochlorite 
NEM  N-ethylmaleimide 
OD500  optical density at 500 nm 
OxD   oxidation degree 
PBS  phosphate-buffered saline 
Rdw   raw dry weight 
roGFP  redox-sensitive green fluorescent protein 
ROS  reactive oxygen species 
Trx  thioredoxin  
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FIGURE LEGENDS 
Figure 1: Structure of the bacilliredoxin (Brx) SAUSA300_1321 (A), Brx electron pathway (B), 
principle of the Brx-roGFP2 redox pathway (C) and excitation spectra of Brx-roGFP2 and 
roGFP2 (A) Bacilliredoxins are Trx-fold proteins of the UPF0403 family with an unusual CGC active 
site motif. The structure of Brx (SAUSA300_1321) was generated using the software Phyre2 and 
PyMol (B) The S-bacillithiolated proteins are reduced by bacilliredoxins (Brx) leading to Brx-SSB 
formation. Regeneration of Brx requires BSH and the putative NADPH-dependent BSSB reductase 
YpdA. (C) In the Brx-roGFP2 fusion, Brx reacts with BSSB leading to Brx-SSB formation, subsequent 
transfer of the BSH moiety to the coupled roGFP2 and re-arrangement to the roGFP2 disulfide. The 
roGFP2 disulfide causes a change of the 405/488 nm excitation ratio. (D, E) Purified roGFP2 and Brx-
roGFP2 were fully oxidized and reduced with 5 mM diamide and 10 mM DTT, respectively, and the 
fluorescence excitation spectra were monitored using the microplate reader (n=7-9, P<0.0001 in all 
samples). In all graphs mean values are shown, error bars represent the s.e.m and P-values were 
calculated using a Students unpaired two-tailed t-Test by the graph prism software. 
 
Figure 2: Responses of purified Brx-roGFP2, Grx1-roGFP2 and roGFP2 in vitro to BSSB, GSSG, 
MSSM, cystine and CoAS-disulfide. (A,B) Brx-roGFP2 responds specifically to 10 µM and 100 µM 
BSSB in vitro but is non-responsive to GSSG, MSSM, cystine and CoAS-disulfide (n=3, P<0.0045 for 
10 µM and P<0.01 for 100 µM in all samples). (C) The roGFP2 probe does not respond to 100µM thiol 
disulfides (n=3; P<0.0001 for BSSB, GSSG, MSSM; P=0.93 for cystine). (D) The Grx1-roGFP2 fusion 
shows a specific response to 100µM GSSG, but not to other thiol disulfides (n=3; P<0.0033 for all 
samples). (E,F) The response of Brx-roGFP2 to 10µM (E) and 100µM BSSB (F) was compared to the 
Brx-Cys mutant proteins BrxAGC-roGFP2, BrxCGA-roGFP2, BrxAGA-roGFP2 and roGFP2 (n=3, 
P=0.27 for 10 µM BSSB BrxAGA; P<0.0001 for all others). The results showed that the Brx-roGFP2 
response depends on the active site Cys54 of Brx. The thiol disulfides were injected into the microplate 
wells 90 seconds after the start of measurements and the biosensor response and oxidation degree 
(OxD) were analyzed using the CLARIOstar microplate reader. In all graphs mean values are shown, 
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error bars represent the s.e.m and P-values were calculated using a Students unpaired two-tailed t-
Test by the graph prism software.  
 
Figure 3. Comparison of the Brx-roGFP2 response and expression in S. aureus COL and 
USA300 wild type and bshA mutants during the growth. (A,B) Ratiometric response of Brx-
roGFP2 in S. aureus COL and USA300 after oxidation of cells by 5 mM diamide and reduction by 
10 mM DTT (n=7-8; P<0.0001 in all samples). (C, D) Expression of Brx-roGFP2 is higher in S. aureus 
COL compared to USA300 during the log phase (n=3; P<0.0001 at OD1-1.5) and (E) the oxidation 
degree (OxD) is increased during the stationary phase most strongly in USA300 (n=3; P=0.0009 at 6 
hours). (F) The dynamic range of Brx-roGFP2 is higher in S. aureus COL compared to USA300 (n=3; 
P=0.0159 DTT; P=0.0436 Diamide). (G, H) The Brx-roGFP2 biosensor is constitutively oxidized in the 
S. aureus COL and USA300 bshA mutants in comparison to the wild type strains (n=3; P<0.0001 in 
COL all time points, P<0.01 in USA300 at 4-5.5 hours). Symbols are defined as: ns (P>0.05); * 
(P≤0.05); ** (P≤0.01); *** (P≤0.001); **** (P≤ 0.0001). The oxidation degree was calculated based on 
405/488 nm excitation ratios with emission at 510 nm and related to the fully oxidized and reduced 
controls as described in the Methods section. In all graphs mean values are shown, error bars 
represent the s.e.m and P-values were calculated using a Students unpaired two-tailed t-Test by the 
graph prism software. 
 
Figure 4: Effect of NaOCl and H2O2 on the survival of S. aureus wild type and bshA mutants 
and oxidative stress responses of Brx-roGFP2 and Brx Cys-mutant fusions in S. aureus COL. 
(A, B) The S. aureus COL and USA300 bshA mutants are more sensitive to NaOCl and H2O2 stress 
compared to the wild type as revealed by survival assays (n=3; P=0.0473 at 300 mM H2O2; P=0.0126 
at 30’ 150 µM NaOCl). (C, D) The Brx-roGFP2 biosensor in S. aureus COL is rapidly and reversibly 
oxidized by sub-lethal concentrations of 1-50 mM H
2
O
2
 and 10-20 µM NaOCl while higher doses result 
in constitutive biosensor oxidation (n=4; P=0.3186 at 1 mM H2O2, P<0.0001 in all other samples). (E, 
F) The response of Brx-roGFP2 and BrxCGA-roGFP2 to H2O2 and NaOCl is reversible compared to 
the active Cys Brx mutant fusions in S. aureus COL which is not reversible (n=5; P<0.0001 all 
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samples). In all graphs mean values are shown, error bars represent the s.e.m and P-values were 
calculated using a Students unpaired two-tailed t-Test by the graph prism software. 
 
Figure 5: Confocal laser scanning microscopy of S. aureus COL Brx-roGFP2 wild type and the 
bshA mutant during NaOCl stress. (A, B) S. aureus COL Brx-roGFP2 wild type and bshA mutant 
strains were exposed to 150 µM NaOCl, blocked with NEM and analyzed using CLSM. Cells treated 
with 10 mM DTT and 5 mM diamide were used as fully reduced and oxidized controls, respectively. 
Fluorescence emission was measured at 505-550 nm after excitation at 405 nm and 488 nm. 
Fluorescence intensities at the 488 nm and 405 nm excitation maxima are false-coloured in green and 
red, respectively and shown in the overlay images and histograms for single cells. The NaOCl-induced 
oxidation in the wild type and constitutive oxidation of the biosensor in the ΔbshA mutant are visualized 
by the overlay images and the cells are encircled based on the transmitted light image. The histograms 
show average fluorescence intensities at 405 and 488 nm calculated from 5 representative single 
cells. (C) The average 405/488 nm ratios of the wild type and bshA mutant samples were calculated 
from 5 representative single cells each for the wild type and bshA mutant that are marked with bold 
circles (n=5; P=0.001 for control WT/bshA). (D) For comparison, the 405/488 nm ratios were also 
calculated from the same S. aureus samples using the microplate reader (n=3; P=0.0009 for control 
WT/bshA). In all graphs mean values are shown, error bars represent the s.e.m and P-values were 
calculated using a Students unpaired two-tailed t-Test by the graph prism software. 
  
Figure 6. Growth curves and OxD of S. aureus COL Brx-roGFP2 with sub-lethal concentrations 
of antibiotics that reduced the growth rate. S. aureus was exposed to sub-lethal concentrations of 
antibiotics at an OD500 of 0.5 and the OxD of Brx-roGFP2 was monitored in treated and untreated 
cells (n=4; P>0.05 for OxD control/antibiotics treatment in all samples). The following sub-lethal 
antibiotics were used: 0.1 µM erythromycin, 0.1 µM rifampicin, 5 µM vancomycin, 30 µM ciprofloxacin, 
0.1 µM gentamycin, 10 µM ampicillin, 50 mM fosfomycin, 5 µM lincomycin, 2 µg/ml linezolid, 2 mM 
oxacillin. There was no increased oxidation by antibiotics in S. aureus. In all graphs mean values are 
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shown, error bars represent the s.e.m and P-values were calculated using a Students unpaired two-
tailed t-Test by the graph prism software. 
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